Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02519452 |
| Title | A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | SWE | NLD | FRA | ESP | DNK |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Atlanta | Georgia | United States | Details | |||
| New York | New York | United States | Details | |||
| Charlotte | North Carolina | United States | Details | |||
| Philadelphia | Pennsylvania | United States | Details | |||
| Vejle | Denmark | Details | ||||
| Nantes Cedex 1 | France | Details | ||||
| Tours cedex | France | Details | ||||
| Amsterdam | Netherlands | Details | ||||
| Badalona | Spain | Details | ||||
| Pamplona | Spain | Details | ||||
| Salamanca | Spain | Details | ||||
| Stockholm | Sweden | Details |